Results for tag: "Sick Sinus Syndrome Drug"

Sick Sinus Syndrome (SSS) is a type of cardiac arrhythmia that affects the heart's ability to regulate its own rhythm. It is caused by a malfunction of the sinoatrial node, which is responsible for controlling the heart rate. Treatment for SSS typically involves the use of antiarrhythmic drugs, such as beta-blockers, calcium channel blockers, and digoxin. These drugs are used to slow the heart rate and restore normal rhythm. In addition, pacemakers may be used to regulate the heart rate. The Sick Sinus Syndrome Drug market is a subset of the larger Cardiovascular Drugs market. It is composed of a variety of drugs used to treat SSS, as well as pacemakers and other medical devices. The market is driven by the increasing prevalence of SSS, as well as the need for effective treatments. Some companies in the Sick Sinus Syndrome Drug market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. These companies produce a variety of drugs and medical devices used to treat SSS. Show Less Read more